AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36689726 — intervention group
Group type: EXPERIMENTAL
Intervention: Acalabrutinib monotherapy
Number of subjects: 38
Study 36689746 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose exercise therapy (patient-tailored exercise programs, 3 times a week for 12 weeks)
Number of subjects: 189
Study 36689746 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose exercise therapy
Number of subjects: 189
Study 36689746 — intervention group
Group type: COMPARATOR
Intervention: Low-dose exercise therapy (patient-tailored exercise programs, 3 times a week for 12 weeks)
Number of subjects: 189
Study 36689927 — intervention group
Group type: EXPERIMENTAL
Intervention: rPAP
Number of subjects: 0
Study 36689927 — intervention group
Group type: COMPARATOR
Intervention: standard T-piece
Number of subjects: 0
Study 36690030 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrow-band imaging (NBI)
Number of subjects: 203
Study 36690030 — intervention group
Group type: COMPARATOR
Intervention: White-light endoscopy (WLE)
Number of subjects: 203
Study 36690072 — intervention group
Group type: EXPERIMENTAL
Intervention: Liberal transfusion strategy (Hb <10 g/dL to Hb ≥10 g/dL)
Number of subjects: 1520
Study 36690072 — intervention group
Group type: COMPARATOR
Intervention: Restrictive transfusion strategy (Hb <7 g/dL to Hb ≥7 g/dL)
Number of subjects: 1520
Study 36690136 — intervention group
Group type: COMPARATOR
Intervention: Mild congestion (CCS ≤3)
Number of subjects: 3787
Study 36690136 — intervention group
Group type: COMPARATOR
Intervention: Moderate congestion (CCS = 4 or 5)
Number of subjects: 3787
Study 36690136 — intervention group
Group type: COMPARATOR
Intervention: Severe congestion (CCS ≥6)
Number of subjects: 3787
Study 36690136 — intervention group
Group type: COMPARATOR
Intervention: Residual congestion at discharge (CCS of 1 or more)
Number of subjects: 3787
Study 36690136 — intervention group
Group type: COMPARATOR
Intervention: Complete decongestion at discharge (CCS of 0)
Number of subjects: 3787
Study 36690181 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold soda water solution
Number of subjects: 399
Study 36690181 — intervention group
Group type: EXPERIMENTAL
Intervention: Any-temperature glucose solution containing a tea bag
Number of subjects: 399
Study 36690181 — intervention group
Group type: COMPARATOR
Intervention: Room-temperature water-based glucose solution
Number of subjects: 399
Study 36690181 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose formula
Number of subjects: 399
Study 36690388 — intervention group
Group type: EXPERIMENTAL
Intervention: Anifrolumab
Number of subjects: 819
Study 36690388 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 819
Study 36690404 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (DEX) infusion at a rate of 0.4 µg/kg/hour until surgical haemostasis
Number of subjects: 0
Study 36690404 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 0
Study 36690404 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (DEX) infusion
Number of subjects: 0
Study 36690406 — intervention group
Group type: EXPERIMENTAL
Intervention: Letermovir treatment
Number of subjects: 60
Study 36690406 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 60
Study 36690415 — intervention group
Group type: EXPERIMENTAL
Intervention: IO-palliative care nurse training programme
Number of subjects: 24
Study 36690538 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnosis
Number of subjects: 60
Study 36690550 — intervention group
Group type: EXPERIMENTAL
Intervention: DGAT2 inhibitor ervogastat (PF-06865571)
Number of subjects: 0
Study 36690550 — intervention group
Group type: COMPARATOR
Intervention: DGAT1 inhibitor PF-04620110
Number of subjects: 0
Study 36690550 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 36690561 — intervention group
Group type: EXPERIMENTAL
Intervention: DTaP/IPV
Number of subjects: 132
Study 36690561 — intervention group
Group type: COMPARATOR
Intervention: Control (no DTaP/IPV)
Number of subjects: 132
Study 36690571 — intervention group
Group type: EXPERIMENTAL
Intervention: secukinumab 300 mg
Number of subjects: 82
Study 36690598 — intervention group
Group type: EXPERIMENTAL
Intervention: Infrared flashing light
Number of subjects: 22
Study 36690598 — intervention group
Group type: COMPARATOR
Intervention: Conventional technique (without infrared flashing light)
Number of subjects: 22
Study 36690607 — intervention group
Group type: EXPERIMENTAL
Intervention: Activity-based locomotor training (ABLT)
Number of subjects: 7
Study 36690734 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone-sparing regimen with NEPA (netupitant/palonosetron fixed combination)
Number of subjects: 0
Study 36690734 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone-sparing regimen with NEPA
Number of subjects: 0
Study 36690839 — intervention group
Group type: EXPERIMENTAL
Intervention: TMPRSS6-targeted therapy (specific intervention details not provided)
Number of subjects: 0
Study 36690932 — intervention group
Group type: EXPERIMENTAL
Intervention: E/e' at 4 months adjusted for E/e' at hospitalization
Number of subjects: 267
Study 36690932 — intervention group
Group type: EXPERIMENTAL
Intervention: Change in E/e' between hospitalization and 4 months
Number of subjects: 267
Study 36690940 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-delivered mental health course based on cognitive behavioral techniques, no specific dosage or duration mentioned.
Number of subjects: 91
Study 36690974 — intervention group
Group type: EXPERIMENTAL
Intervention: Interprofessional team training (4-h interdisciplinary training session based on psychological theories)
Number of subjects: 2865
Study 36690974 — intervention group
Group type: EXPERIMENTAL
Intervention: Interprofessional team training
Number of subjects: 2865
Study 36691000 — intervention group
Group type: EXPERIMENTAL
Intervention: Elective adhesiolysis
Number of subjects: 122
Study 36691000 — intervention group
Group type: COMPARATOR
Intervention: Non-operative treatment
Number of subjects: 122
Study 36691000 — intervention group
Group type: EXPERIMENTAL
Intervention: Elective adhesiolysis (in patients with previous ASBO)
Number of subjects: 122
Study 36691000 — intervention group
Group type: COMPARATOR
Intervention: Non-operative treatment (in patients with previous ASBO)
Number of subjects: 122
Study 36691000 — intervention group
Group type: EXPERIMENTAL
Intervention: Previous episodes of ASBO
Number of subjects: 122
Study 36691039 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual reality-based cognitive behavioral therapy (VR-CBT)
Number of subjects: 0
Study 36691039 — intervention group
Group type: COMPARATOR
Intervention: Standard cognitive behavioral therapy (CBT)
Number of subjects: 0
Study 36691060 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical Decision Aid Group (AI-powered clinical decision aid tool in addition to current practice)
Number of subjects: 200
Study 36691060 — intervention group
Group type: COMPARATOR
Intervention: Control Group (current practice)
Number of subjects: 200
Study 36691061 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition counseling intervention group (IG)
Number of subjects: 120
Study 36691061 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 120
Study 36691082 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemoadsorption (HA) with CytoSorb
Number of subjects: 21
Study 36691082 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 21
Study 36691103 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Navigation (FN) + Usual Care
Number of subjects: 108
Study 36691103 — intervention group
Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 108
Study 36691127 — intervention group
Group type: EXPERIMENTAL
Intervention: Chess-based cognitive remediation training (CB-CRT) as a therapy add-on for 6 weeks
Number of subjects: 96
Study 36691127 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual for AUD in a clinic
Number of subjects: 96
Study 36691127 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual for TUD outpatient treatment
Number of subjects: 96
Study 36691129 — intervention group
Group type: EXPERIMENTAL
Intervention: Prefabricated contoured foot orthoses
Number of subjects: 28
Study 36691129 — intervention group
Group type: COMPARATOR
Intervention: Flat shoe inserts (Control)
Number of subjects: 28
Study 36691137 — intervention group
Group type: EXPERIMENTAL
Intervention: Er:YAG laser therapy with 'Latent inhibition' as anxiety-management technique
Number of subjects: 0
Study 36691137 — intervention group
Group type: COMPARATOR
Intervention: Conventional rotary instruments with 'Latent inhibition' as anxiety-management technique
Number of subjects: 0
Study 36691152 — intervention group
Group type: EXPERIMENTAL
Intervention: ODYSSEE-vCHAT via Internet-connected personal computer
Number of subjects: 162
Study 36691152 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 162
Study 36691157 — intervention group
Group type: EXPERIMENTAL
Intervention: Urgent endoscopy (within 6 hours after gastroenterological consultation)
Number of subjects: 400
Study 36691157 — intervention group
Group type: COMPARATOR
Intervention: Non-urgent endoscopy (between 6 hours and 24 hours after gastroenterological consultation)
Number of subjects: 400
Study 36691157 — intervention group
Group type: EXPERIMENTAL
Intervention: Urgent endoscopy
Number of subjects: 400
Study 36691157 — intervention group
Group type: COMPARATOR
Intervention: Non-urgent endoscopy
Number of subjects: 400
Study 36691165 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ferric derisomaltose administered approximately 3 months prior to TAVI
Number of subjects: 150
Study 36691165 — intervention group
Group type: COMPARATOR
Intervention: Placebo administered approximately 3 months prior to TAVI
Number of subjects: 150
Study 36691165 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ferric derisomaltose
Number of subjects: 150
Study 36691165 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study 36691167 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate and continuous heart rate feedback by dry electrode ECG
Number of subjects: 169
Study 36691167 — intervention group
Group type: COMPARATOR
Intervention: Standard HR assessment (stethoscope, gel-electrode ECG, pulse oximetry)
Number of subjects: 169
Study 36691183 — intervention group
Group type: EXPERIMENTAL
Intervention: Online mindfulness-based intervention (MBI) groups for mothers with PPDA and their partners, duration: 8 weeks
Number of subjects: 0
Study 36691184 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy
Number of subjects: 37
Study 36691184 — intervention group
Group type: COMPARATOR
Intervention: Pre-chemotherapy
Number of subjects: 37
Study 36691184 — intervention group
Group type: COMPARATOR
Intervention: Post-chemotherapy
Number of subjects: 37
Study 36691193 — intervention group
Group type: EXPERIMENTAL
Intervention: Home visits intervention to improve access to tailored care
Number of subjects: 157
Study 36691193 — intervention group
Group type: EXPERIMENTAL
Intervention: Nominal Group Technique (NGT)
Number of subjects: 157
Study 36691209 — intervention group
Group type: EXPERIMENTAL
Intervention: HCV self-testing (HCVST) delivered to the home via courier or peer delivery
Number of subjects: 1250
Study 36691209 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care HCV testing at testing sites (control)
Number of subjects: 1250
Study 36691214 — intervention group
Group type: EXPERIMENTAL
Intervention: mpMR scan (annual for moderate/severe AIH patients)
Number of subjects: 200
Study 36691214 — intervention group
Group type: EXPERIMENTAL
Intervention: mpMR scan (three scans over 5 years for mild/moderate AIH patients)
Number of subjects: 200
Study 36691214 — intervention group
Group type: EXPERIMENTAL
Intervention: mpMR scan (increased frequency from 5 to 10 scans over 5 years for moderate/severe AIH patients)
Number of subjects: 200
Study 36691214 — intervention group
Group type: EXPERIMENTAL
Intervention: mpMR scan (increased frequency from 3 to 6 scans over 5 years for mild/moderate AIH patients)
Number of subjects: 200
Study 36691214 — intervention group
Group type: EXPERIMENTAL
Intervention: mpMR scan (5 scans replacing two biopsies over 5 years for all patients)
Number of subjects: 200
Study 36691234 — intervention group
Group type: EXPERIMENTAL
Intervention: Distress measured by the Hopkins 25-item symptom checklist
Number of subjects: 100
Study 36691234 — intervention group
Group type: EXPERIMENTAL
Intervention: Inflammatory reactivity (IR) measured by multiplex assay after LPS challenge
Number of subjects: 100
Study 36691234 — intervention group
Group type: EXPERIMENTAL
Intervention: Persistent pain (PP) measured by the Brief Pain Inventory
Number of subjects: 100
Study 36691234 — intervention group
Group type: EXPERIMENTAL
Intervention: Induced secondary hyperalgesia (SH)
Number of subjects: 100
Study 36691234 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediation analysis using baseline data from the PP group
Number of subjects: 100
Study 36691234 — intervention group
Group type: EXPERIMENTAL
Intervention: Generalised mixed effects models analysis of IR and SH
Number of subjects: 100
Study 36691248 — intervention group
Group type: EXPERIMENTAL
Intervention: Penicillin allergy assessment pathway
Number of subjects: 89
Study 36691248 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 89
Study 36691523 — intervention group
Group type: EXPERIMENTAL
Intervention: LAAC procedure using the WATCHMAN device with standard protocol (simple group)
Number of subjects: 802
Study 36691523 — intervention group
Group type: EXPERIMENTAL
Intervention: LAAC procedure with sheath depth less than device depth (complex group)
Number of subjects: 802
Study 36691523 — intervention group
Group type: EXPERIMENTAL
Intervention: Re-ATP procedure
Number of subjects: 802
Study 36691523 — intervention group
Group type: EXPERIMENTAL
Intervention: Successful procedures after re-ATP
Number of subjects: 802
Study 36691723 — intervention group
Group type: EXPERIMENTAL
Intervention: Interatrial shunt device (IASD) placement in patients with latent PVD
Number of subjects: 75
Study 36691723 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise stress
Number of subjects: 75
Study 36691723 — intervention group
Group type: EXPERIMENTAL
Intervention: CMR imaging
Number of subjects: 75
Study 36691862 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal cord stimulation systems
Number of subjects: 0
Study 36691880 — intervention group
Group type: EXPERIMENTAL
Intervention: Ostomy placement that meets international guidelines
Number of subjects: 160
Study 36691880 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimal relationship with health professionals
Number of subjects: 160
Study 36691880 — intervention group
Group type: EXPERIMENTAL
Intervention: Proper knowledge and skills in ostomy care
Number of subjects: 160
Study 36691880 — intervention group
Group type: EXPERIMENTAL
Intervention: Colostomy
Number of subjects: 160
Study 36691880 — intervention group
Group type: EXPERIMENTAL
Intervention: Convex baseplate
Number of subjects: 160
Study 36691880 — intervention group
Group type: EXPERIMENTAL
Intervention: Oval ostomy
Number of subjects: 160
Study 36691880 — intervention group
Group type: EXPERIMENTAL
Intervention: Independence in ostomy care
Number of subjects: 160
Study 36691990 — intervention group
Group type: EXPERIMENTAL
Intervention: Bayesian quantile regression (BQR) model
Number of subjects: 1463
Study 36692020 — intervention group
Group type: EXPERIMENTAL
Intervention: 200,000 IU cholecalciferol (vitamin D3)
Number of subjects: 28
Study 36692020 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 36692019 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed fractional (DFx) dosing schedule (0-1-6 month)
Number of subjects: 0
Study 36692019 — intervention group
Group type: COMPARATOR
Intervention: Monthly dosing schedule (0-1-2 month)
Number of subjects: 0
Study 36692109 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic-assisted laparoscopic surgery (RALS)
Number of subjects: 300
Study 36692166 — intervention group
Group type: EXPERIMENTAL
Intervention: ANNE Sleep system
Number of subjects: 105
Study 36692172 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative ultrasound assessment of closure device deployment
Number of subjects: 650
Study 36692172 — intervention group
Group type: COMPARATOR
Intervention: No intraoperative ultrasound assessment of closure device deployment
Number of subjects: 650
Study 36692172 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall procedure
Number of subjects: 650
Study 36692418 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab 40 mg subcutaneously every 2 weeks
Number of subjects: 100
Study 36692475 — intervention group
Group type: EXPERIMENTAL
Intervention: Polypharmacy (defined as the concurrent use of eight or more medications)
Number of subjects: 718
Study 36692475 — intervention group
Group type: EXPERIMENTAL
Intervention: One or more major potential drug interactions (PDIs)
Number of subjects: 718
Study 36692681 — intervention group
Group type: EXPERIMENTAL
Intervention: Nintedanib
Number of subjects: 5578
Study 36692682 — intervention group
Group type: EXPERIMENTAL
Intervention: One-time point SPECT imaging at 168 h
Number of subjects: 10
Study 36692682 — intervention group
Group type: EXPERIMENTAL
Intervention: Including a second time point SPECT imaging
Number of subjects: 10
Study 36692682 — intervention group
Group type: EXPERIMENTAL
Intervention: Single SPECT at 24 h or 48 h for organ dosimetry
Number of subjects: 10
Study 36692682 — intervention group
Group type: EXPERIMENTAL
Intervention: Planar scans for dosimetry
Number of subjects: 10
Study 36692933 — intervention group
Group type: EXPERIMENTAL
Intervention: Young Melanoma Family Facebook Group
Number of subjects: 1154
Study 36692933 — intervention group
Group type: COMPARATOR
Intervention: Melanoma Family Healthy Lifestyle Facebook Group
Number of subjects: 1154
Study 36692933 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 1154
Study 36692939 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality Exposure Therapy (VR-ET)
Number of subjects: 18
Study 36692945 — intervention group
Group type: EXPERIMENTAL
Intervention: MiniMed 780G advanced hybrid closed-loop (AHCL) system
Number of subjects: 41
Study 36692945 — intervention group
Group type: COMPARATOR
Intervention: MDI + SMBG (Control)
Number of subjects: 41
Study 36692954 — intervention group
Group type: EXPERIMENTAL
Intervention: H1 coil (Deep TMS targeting the lateral prefrontal cortex)
Number of subjects: 169
Study 36692954 — intervention group
Group type: EXPERIMENTAL
Intervention: H7 coil (Deep TMS targeting the medial prefrontal cortex)
Number of subjects: 169
Study 36692954 — intervention group
Group type: COMPARATOR
Intervention: Both H1 and H7 coils
Number of subjects: 169
Study 36693062 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamified live feedback intervention (Intervention A) with instructions
Number of subjects: 106
Study 36693062 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamified live feedback intervention (Intervention B) with instructions and a reward
Number of subjects: 106
Study 36693062 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamified live feedback intervention (Intervention C) with instructions from the screen but no reward
Number of subjects: 106
Study 36693062 — intervention group
Group type: COMPARATOR
Intervention: Control group with no screen activity
Number of subjects: 106
Study 36693146 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple aspiration
Number of subjects: 0
Study 36693146 — intervention group
Group type: COMPARATOR
Intervention: Drainage
Number of subjects: 0
Study 36693175 — intervention group
Group type: EXPERIMENTAL
Intervention: Palbociclib combined with letrozole or fulvestrant
Number of subjects: 51
Study 36693400 — intervention group
Group type: EXPERIMENTAL
Intervention: Early mobilisation
Number of subjects: 200
Study 36693400 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 200
Study 36693402 — intervention group
Group type: EXPERIMENTAL
Intervention: Continued enteral nutrition until extubation
Number of subjects: 1130
Study 36693402 — intervention group
Group type: COMPARATOR
Intervention: Fasting before extubation
Number of subjects: 1130
Study 36693403 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-invasive ventilation (NIV)
Number of subjects: 981
Study 36693403 — intervention group
Group type: COMPARATOR
Intervention: Oxygen therapy (HFNO or standard oxygen)
Number of subjects: 981
Study 36693401 — intervention group
Group type: EXPERIMENTAL
Intervention: Separation attempts from mechanical ventilation
Number of subjects: 5869
Study 36693401 — intervention group
Group type: EXPERIMENTAL
Intervention: Successful weaning from mechanical ventilation
Number of subjects: 5869
Study 36693401 — intervention group
Group type: COMPARATOR
Intervention: Transfer before separation attempt
Number of subjects: 5869
Study 36693401 — intervention group
Group type: COMPARATOR
Intervention: Transfer after separation attempt
Number of subjects: 5869
Study 36693401 — intervention group
Group type: COMPARATOR
Intervention: Death while invasively ventilated
Number of subjects: 5869
Study 36693401 — intervention group
Group type: EXPERIMENTAL
Intervention: Delay in initiating first separation attempt
Number of subjects: 5869
Study 36693401 — intervention group
Group type: EXPERIMENTAL
Intervention: Short wean (≤1 day)
Number of subjects: 5869
Study 36693401 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermediate weaning (2-6 days)
Number of subjects: 5869
Study 36693401 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged weaning (≥7 days)
Number of subjects: 5869
Study 36693401 — intervention group
Group type: EXPERIMENTAL
Intervention: Weaning failure
Number of subjects: 5869
Study 36693401 — intervention group
Group type: COMPARATOR
Intervention: Death in the intensive care unit
Number of subjects: 5869
Study 36693401 — intervention group
Group type: COMPARATOR
Intervention: Death in hospital
Number of subjects: 5869
Study 36693589 — intervention group
Group type: EXPERIMENTAL
Intervention: ACT+MBRP (Acceptance and Commitment Therapy + Mindfulness-Based Relapse Prevention)
Number of subjects: 160
Study 36693589 — intervention group
Group type: COMPARATOR
Intervention: Education control condition
Number of subjects: 160
Study 36693589 — intervention group
Group type: EXPERIMENTAL
Intervention: ACT+MBRP
Number of subjects: 160
Study 36693654 — intervention group
Group type: EXPERIMENTAL
Intervention: Near infrared spectroscopy plus standard care
Number of subjects: 607
Study 36693654 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 607
Study 36693686 — intervention group
Group type: EXPERIMENTAL
Intervention: Previous calf IMI frequency
Number of subjects: 134
Study 36693686 — intervention group
Group type: EXPERIMENTAL
Intervention: Hamstring IMI frequency
Number of subjects: 134